Lornoxicam
Alternative Names: Bosporon; Chlortenoxicam; HN 10000; RO 139297; Safem; TS 110; XefoLatest Information Update: 08 Feb 2019
At a glance
- Originator Roche
- Developer POZEN; Takeda Pharmaceuticals International GmbH
- Class Antirheumatics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Neuropathic pain; Osteoarthritis; Pain; Postoperative pain; Rheumatic disorders
- Discontinued Migraine